MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
A8780 WM-2474Summary: Inactive analogue of WM-8014, used as control compound -
N2399 ArctigeninSummary: Anti-inflammatory, antiproliferative -
C4361 PD 184161Summary: MEK1/2 inhibitor -
B7124 PD 198306Summary: MEK1/2 inhibitor -
B6882 U0124Summary: Inactive analog of U0126(MEK-1/2 inhibitor), used as a negative control -
B6014 BI-847325Summary: dual inhibitor of MEK and Aurora kinases -
B5867 SCH772984 TFASummary: ERK1/2 inhibitor -
B5866 SCH772984 HClSummary: ERK1/2 inhibitor -
B5820 RO5126766(CH5126766)Summary: Raf/MEK dual inhibitor -
B5817 GDC-09942 CitationSummary: ERK1/2 inhibitor
